{
  "company": "Revvity",
  "ticker": "RVTY",
  "period": {
    "from": "2026-03-06",
    "to": "2026-04-05",
    "days": 30
  },
  "sentiment_breakdown": {
    "positive": 8,
    "negative": 5,
    "neutral": 5
  },
  "synthesis": {
    "executive_summary": "Sentiment analysis for Revvity (RVTY) from 2026-03-06 to 2026-04-05. Analyzed 18 items across FDA and news sources.",
    "key_findings": [],
    "overall_sentiment": "neutral"
  },
  "top_positive": [
    {
      "title": "Nephron Research gets more bullish on Revvity, upgrades shares",
      "date": "2026-03-26",
      "source": "news",
      "score": 0.991
    },
    {
      "title": "[Latest] Global Environmental Mass Spectrometry Market Size/Share Worth USD 6.47 Billion by 2035 at a 7.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)",
      "date": "2026-04-02",
      "source": "news",
      "score": 0.859
    },
    {
      "title": "COVID-19 Tests Market Report 2025: Segments, Share, Regulatory, Reimbursement, and Forecasts to 2036",
      "date": "2026-03-12",
      "source": "news",
      "score": 0.859
    },
    {
      "title": "Catabolism of extracellular glutathione supplies cysteine to support tumours",
      "date": "2026-03-18",
      "source": "news",
      "score": 0.856
    },
    {
      "title": "A structure-based mRNA vaccine for Nipah virus in healthy adults: a phase 1 trial",
      "date": "2026-03-12",
      "source": "news",
      "score": 0.852
    },
    {
      "title": "Gene Expression Analysis Market Size to Reach USD 11.53 Billion by 2035; Growth is Propelling Owing to Continuous Growth of Genomics Research Globally | SNS Insider",
      "date": "2026-03-09",
      "source": "news",
      "score": 0.66
    },
    {
      "title": "Emerald Growth Equity Strategy Sold Revvity (RVTY) in Q4",
      "date": "2026-03-16",
      "source": "news",
      "score": 0.382
    },
    {
      "title": "Here’s Artisan Mid Cap Value Fund’s Investment Thesis for Revvity (RVTY)",
      "date": "2026-04-01",
      "source": "news",
      "score": 0.34
    }
  ],
  "top_negative": [
    {
      "title": "The E3 ubiquitin ligase mechanism specifying targeted microRNA degradation",
      "date": "2026-03-18",
      "source": "news",
      "score": -0.778
    },
    {
      "title": "Ectopic NMDAR expression in cancer unmasks germline-encoded autoimmunity",
      "date": "2026-03-25",
      "source": "news",
      "score": -0.66
    },
    {
      "title": "Epigenetics Market to Surpass US $35.84 Billion by 2031, Fuelled by Rising Prevalence of Cancer - Latest Industry Research by The Insight Partners",
      "date": "2026-03-11",
      "source": "news",
      "score": -0.66
    },
    {
      "title": "A µ-opioid receptor superagonist analgesic with minimal adverse effects",
      "date": "2026-04-01",
      "source": "news",
      "score": -0.612
    },
    {
      "title": "Is Revvity Stock Underperforming the S&P 500?",
      "date": "2026-03-20",
      "source": "news",
      "score": -0.2
    }
  ],
  "raw_data": {
    "total_items": 18,
    "items": [
      {
        "source": "news",
        "source_name": "GlobeNewswire",
        "title": "[Latest] Global Environmental Mass Spectrometry Market Size/Share Worth USD 6.47 Billion by 2035 at a 7.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)",
        "description": "[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Environmental Mass Spectrometry Market size & share revenue was valued at approximately USD 2.84 Billion in 2025 and is expected…",
        "url": "https://www.globenewswire.com/news-release/2026/04/02/3267246/0/en/Latest-Global-Environmental-Mass-Spectrometry-Market-Size-Share-Worth-USD-6-47-Billion-by-2035-at-a-7-6-CAGR-Custom-Market-Insights-Analysis-Outlook-Leaders-Report-Trends-Forecast-.html",
        "date": "2026-04-02",
        "published_at": "2026-04-02T11:30:00Z",
        "sentiment": {
          "label": "positive",
          "score": 0.859,
          "confidence": 0.86
        }
      },
      {
        "source": "news",
        "source_name": "Yahoo Entertainment",
        "title": "Here’s Artisan Mid Cap Value Fund’s Investment Thesis for Revvity (RVTY)",
        "description": "",
        "url": "https://consent.yahoo.com/v2/collectConsent?sessionId=1_cc-session_c5216dc8-8c36-4957-a877-72cca4ac0804",
        "date": "2026-04-01",
        "published_at": "2026-04-01T15:04:29Z",
        "sentiment": {
          "label": "positive",
          "score": 0.34,
          "confidence": 0.34
        }
      },
      {
        "source": "news",
        "source_name": "GlobeNewswire",
        "title": "Protein Chip Market Size is Expected to Reach USD 4.79 Billion by 2035 Owing to the Rapid Adoption of Mass-screening Proteomics Technologies Globally | SNS Insider",
        "description": "Protein chip market grows to USD 4.79 Billion by 2035 at 6.89% CAGR, driven by proteomics research, and rising clinical diagnostics adoption....",
        "url": "https://www.globenewswire.com/news-release/2026/04/01/3266380/0/en/Protein-Chip-Market-Size-is-Expected-to-Reach-USD-4-79-Billion-by-2035-Owing-to-the-Rapid-Adoption-of-Mass-screening-Proteomics-Technologies-Globally-SNS-Insider.html",
        "date": "2026-04-01",
        "published_at": "2026-04-01T09:30:00Z",
        "sentiment": {
          "label": "neutral",
          "score": 0.026,
          "confidence": 0.03
        }
      },
      {
        "source": "news",
        "source_name": "Nature.com",
        "title": "A µ-opioid receptor superagonist analgesic with minimal adverse effects",
        "description": "N-desethyl-fluornitrazene is a µ-opioid receptor agonist derived from nitazenes that has supramaximal intrinsic efficacy that produces analgesia with minimal adverse effects in rodent models.",
        "url": "https://www.nature.com/articles/s41586-026-10299-9",
        "date": "2026-04-01",
        "published_at": "2026-04-01T00:00:00Z",
        "sentiment": {
          "label": "negative",
          "score": -0.612,
          "confidence": 0.61
        }
      },
      {
        "source": "news",
        "source_name": "Nature.com",
        "title": "Mosaic gastruloids reveal a temporal restriction for developmental cell competition",
        "description": "Frenster et al. utilize mosaic mouse gastruloids as a model of cell fitness and competition, identifying a temporal window between primed pluripotency and early gastrulation during which cell competition occurs in mammalian embryogenesis.",
        "url": "https://www.nature.com/articles/s41556-026-01923-x",
        "date": "2026-04-01",
        "published_at": "2026-04-01T00:00:00Z",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "news",
        "source_name": "Yahoo Entertainment",
        "title": "Stifel Maintains a Hold Rating on Revvity (RVTY)",
        "description": "",
        "url": "https://consent.yahoo.com/v2/collectConsent?sessionId=1_cc-session_5264e652-64a8-4995-bdc5-fa1ad7e19dbd",
        "date": "2026-03-27",
        "published_at": "2026-03-27T07:29:27Z",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "news",
        "source_name": "Thefly.com",
        "title": "Nephron Research gets more bullish on Revvity, upgrades shares",
        "description": "See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active traders, and corpor…",
        "url": "https://www.thefly.com/RVTY",
        "date": "2026-03-26",
        "published_at": "2026-03-26T11:13:51Z",
        "sentiment": {
          "label": "positive",
          "score": 0.991,
          "confidence": 0.99
        }
      },
      {
        "source": "news",
        "source_name": "Nature.com",
        "title": "Ectopic NMDAR expression in cancer unmasks germline-encoded autoimmunity",
        "description": "NMDAR expression is sufficient to induce B cell recruitment and affinity maturation, resulting in receptor-modulating antibodies that connect anti-cancer immunity and autoimmunity.",
        "url": "https://www.nature.com/articles/s41586-026-10278-0",
        "date": "2026-03-25",
        "published_at": "2026-03-25T00:00:00Z",
        "sentiment": {
          "label": "negative",
          "score": -0.66,
          "confidence": 0.66
        }
      },
      {
        "source": "news",
        "source_name": "Yahoo Entertainment",
        "title": "Is Revvity Stock Underperforming the S&P 500?",
        "description": "",
        "url": "https://consent.yahoo.com/v2/collectConsent?sessionId=1_cc-session_0da74d95-ac07-4f8b-a52f-bf2fc7eb9b22",
        "date": "2026-03-20",
        "published_at": "2026-03-20T10:12:04Z",
        "sentiment": {
          "label": "negative",
          "score": -0.2,
          "confidence": 0.2
        }
      },
      {
        "source": "news",
        "source_name": "GlobeNewswire",
        "title": "Genomics Market to Reach USD 85.09 Billion by 2030 | MarketsandMarkets™",
        "description": "Advancements in NGS, AI-driven bioinformatics, and expanding precision medicine initiatives are positioning genomics as a strategic pillar in modern healthcare, diagnostics, and drug discovery. Advancements in NGS, AI-driven bioinformatics, and expanding prec…",
        "url": "https://www.globenewswire.com/news-release/2026/03/19/3259211/0/en/Genomics-Market-to-Reach-USD-85-09-Billion-by-2030-MarketsandMarkets.html",
        "date": "2026-03-19",
        "published_at": "2026-03-19T14:30:00Z",
        "sentiment": {
          "label": "neutral",
          "score": 0.026,
          "confidence": 0.03
        }
      },
      {
        "source": "news",
        "source_name": "Nature.com",
        "title": "Catabolism of extracellular glutathione supplies cysteine to support tumours",
        "description": "Catabolism of extracellular glutathione by γ-glutamyltransferases supports tumour growth and survival, and pharmacological targeting of these enzymes slows tumour growth.",
        "url": "https://www.nature.com/articles/s41586-026-10268-2",
        "date": "2026-03-18",
        "published_at": "2026-03-18T00:00:00Z",
        "sentiment": {
          "label": "positive",
          "score": 0.856,
          "confidence": 0.86
        }
      },
      {
        "source": "news",
        "source_name": "Nature.com",
        "title": "The E3 ubiquitin ligase mechanism specifying targeted microRNA degradation",
        "description": "Target-directed microRNA degradation is driven by the atypical ZSWIM8–CUL3 E3 ubiquitin ligase that uses a two-RNA-factor authentication mechanism to specifically recognize AGO–miRNA–trigger RNA complexes and polyubiquitylate AGO.",
        "url": "https://www.nature.com/articles/s41586-026-10232-0",
        "date": "2026-03-18",
        "published_at": "2026-03-18T00:00:00Z",
        "sentiment": {
          "label": "negative",
          "score": -0.778,
          "confidence": 0.78
        }
      },
      {
        "source": "news",
        "source_name": "Yahoo Entertainment",
        "title": "Emerald Growth Equity Strategy Sold Revvity (RVTY) in Q4",
        "description": "",
        "url": "https://consent.yahoo.com/v2/collectConsent?sessionId=1_cc-session_649a11d8-8503-4978-8942-c9108f173957",
        "date": "2026-03-16",
        "published_at": "2026-03-16T13:58:38Z",
        "sentiment": {
          "label": "positive",
          "score": 0.382,
          "confidence": 0.38
        }
      },
      {
        "source": "news",
        "source_name": "GlobeNewswire",
        "title": "Global In Vitro Diagnostics Market to Reach USD 157.63 Billion by 2030 | MarketsandMarkets™",
        "description": "Market Expansion Accelerates as Clinical Laboratories and Healthcare Systems Prioritize Rapid Diagnostics, Automation, and Early Disease Detection Market Expansion Accelerates as Clinical Laboratories and Healthcare Systems Prioritize Rapid Diagnostics, Autom…",
        "url": "https://www.globenewswire.com/news-release/2026/03/12/3254849/0/en/Global-In-Vitro-Diagnostics-Market-to-Reach-USD-157-63-Billion-by-2030-MarketsandMarkets.html",
        "date": "2026-03-12",
        "published_at": "2026-03-12T14:30:00Z",
        "sentiment": {
          "label": "neutral",
          "score": 0.026,
          "confidence": 0.03
        }
      },
      {
        "source": "news",
        "source_name": "GlobeNewswire",
        "title": "COVID-19 Tests Market Report 2025: Segments, Share, Regulatory, Reimbursement, and Forecasts to 2036",
        "description": "Opportunities in the COVID-19 tests market include developing innovative products, leveraging global and regional trends, understanding competitive dynamics, and accessing country-specific regulatory and reimbursement insights. Companies can capitalize on mar…",
        "url": "https://www.globenewswire.com/news-release/2026/03/12/3254589/28124/en/COVID-19-Tests-Market-Report-2025-Segments-Share-Regulatory-Reimbursement-and-Forecasts-to-2036.html",
        "date": "2026-03-12",
        "published_at": "2026-03-12T12:04:00Z",
        "sentiment": {
          "label": "positive",
          "score": 0.859,
          "confidence": 0.86
        }
      },
      {
        "source": "news",
        "source_name": "Nature.com",
        "title": "A structure-based mRNA vaccine for Nipah virus in healthy adults: a phase 1 trial",
        "description": "In this phase 1, open-label dose-escalation study in healthy adults found that the mRNA vaccine (mRNA-1215), encoding the Nipah virus Malaysian strain chimeric pre-fusion F protein linked to glycoprotein G, was safe and induced elevated immune responses at 1 …",
        "url": "https://www.nature.com/articles/s41591-026-04265-1",
        "date": "2026-03-12",
        "published_at": "2026-03-12T00:00:00Z",
        "sentiment": {
          "label": "positive",
          "score": 0.852,
          "confidence": 0.85
        }
      },
      {
        "source": "news",
        "source_name": "GlobeNewswire",
        "title": "Epigenetics Market to Surpass US $35.84 Billion by 2031, Fuelled by Rising Prevalence of Cancer - Latest Industry Research by The Insight Partners",
        "description": "Epigenetics Market is projected to grow from US$ 11.12 billion in 2024 to US$ 35.84 billion by 2031, registering a CAGR of 18.3% ...",
        "url": "https://www.globenewswire.com/news-release/2026/03/11/3253649/0/en/Epigenetics-Market-to-Surpass-US-35-84-Billion-by-2031-Fuelled-by-Rising-Prevalence-of-Cancer-Latest-Industry-Research-by-The-Insight-Partners.html",
        "date": "2026-03-11",
        "published_at": "2026-03-11T11:20:00Z",
        "sentiment": {
          "label": "negative",
          "score": -0.66,
          "confidence": 0.66
        }
      },
      {
        "source": "news",
        "source_name": "GlobeNewswire",
        "title": "Gene Expression Analysis Market Size to Reach USD 11.53 Billion by 2035; Growth is Propelling Owing to Continuous Growth of Genomics Research Globally | SNS Insider",
        "description": "Gene Expression Analysis Market to reach USD 11.53 billion by 2035, driven by genomics research and precision medicine adoption....",
        "url": "https://www.globenewswire.com/news-release/2026/03/09/3251600/0/en/Gene-Expression-Analysis-Market-Size-to-Reach-USD-11-53-Billion-by-2035-Growth-is-Propelling-Owing-to-Continuous-Growth-of-Genomics-Research-Globally-SNS-Insider.html",
        "date": "2026-03-09",
        "published_at": "2026-03-09T09:29:00Z",
        "sentiment": {
          "label": "positive",
          "score": 0.66,
          "confidence": 0.66
        }
      }
    ]
  }
}